The FDA’s New Tzield Approval Fundamentally Alters Stage 3 Pediatric Type 1 Diabetes Management

The FDA’s New Tzield Approval Fundamentally Alters Stage 3 Pediatric Type 1 Diabetes Management

The FDA’s approval of teplizumab for newly diagnosed pediatric Type 1 diabetes marks a shift from insulin replacement toward preserving remaining beta-cell function through immunotherapy.

Jupiter Endovascular Reports Positive Vertex Pulmonary Embolectomy Results

The investigational Vertex Pulmonary Embolectomy System demonstrated promising results in intermediate-risk pulmonary embolism, improving right-heart function and pulmonary pressures while supporting safer, catheter-based clot removal.

Protecting Infants From Measles During Outbreaks: Guidance for Parents and Clinicians

Rapid measles response is critical for infants, who remain highly vulnerable before routine vaccination. Early exposure management, timely immunization, isolation protocols, and coordinated public health action help prevent severe complications, limit transmission, and protect young children during outbreaks.

Carotid Plaque Imaging Enables Improved Carotid Artery Management

Advanced carotid plaque imaging evaluates plaque biology, helping clinicians identify stroke risk more accurately, personalize treatment decisions, and improve prevention beyond stenosis measurement alone.

THT 2026: First-In-Human Smart Implant—Heart Failure Decongestion

A novel smart device for heart failure decongestion uses pressure-guided fluid redistribution to reduce congestion, potentially improving symptoms, lowering hospitalizations, and enabling remote monitoring.